Our team is driven by purpose and supported by a leadership group that proudly champions a balanced, collaborative approach. Together, we are advancing the proprietary activated αβ T-cell immunotherapy. We are working to bring a clinically proven therapy into new healthcare systems, combining global expertise, scientific rigour, and a shared commitment to improving patient outcomes.
20+ years in health, finance, and cross-border partnerships. Leads international investment and medical innovation initiatives across Asia and Australia, translating technology into scalable healthcare ventures.
Co-Founder & Chair
Experienced fund manager and strategist with deep expertise in capital markets, infrastructure, and healthcare. Oversees CellBridge’s financial strategy, operations, and governance.
Co-Founder & CEO
We work closely with:
If you are interested in collaborating with CellBridge Health, we welcome the opportunity to connect.
CellBridge Health
Australia
Lead sponsor, IP holder, governance, capital management
Bioaccell Inc.
Japan
Technology transfer, SOPs, QC training, CPC supervision
AMTZ / BVIC
India
Infrastructure, staff, regulatory facilitation, GMP certification.
Hospital Partner (e.g., KIMS)
Patient recruitment, treatment delivery, follow-up data
Seta Clinic Tokyo
Japan
Clinical training, treatment protocol oversight
Eaton Capital Partners
Australia
Fundraising and investment structuring
